Information
-
Trademark
-
88808578
-
Serial Number
88808578
-
Registration Number
6147100
-
International Classifications
-
Filing Date
February 24, 2020
5 years ago
-
Registration Date
September 08, 2020
4 years ago
-
Transaction Date
February 18, 2022
3 years ago
-
Status Date
September 08, 2020
4 years ago
-
Published for Opposition Date
June 23, 2020
4 years ago
-
Location Date
September 08, 2020
4 years ago
-
First Use Anywhere Date
January 01, 2019
6 years ago
-
First Use In Commerce Date
January 01, 2019
6 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
KEELEY, ALISON REBECCA
-
Attorney Docket Number
45532-TM1001
Attorney Name
Aaron D. Hendelman
Law Office Assigned Location Code
M40
-
Owners
Mark Drawing Code
4000
Mark Identification
AVIDITY
Case File Statements
- GS0421: Research and development in the pharmaceutical and biotechnology fields, namely, research and development for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; research and development for the use of antibody-oligonucleotide conjugates for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical and scientific research services for the use of antibody-oligonucleotide conjugates for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; development of pharmaceutical preparations and medicines, namely, the development of oligonucleotide-based therapeutics
Case File Event Statements
-
2/18/2022 - 3 years ago
13 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
2/18/2022 - 3 years ago
12 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
2/18/2022 - 3 years ago
11 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
2/18/2022 - 3 years ago
10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
2/18/2022 - 3 years ago
9 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
9/8/2020 - 4 years ago
8 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
6/23/2020 - 4 years ago
7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
6/23/2020 - 4 years ago
6 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
6/3/2020 - 4 years ago
5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
5/19/2020 - 4 years ago
4 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
5/12/2020 - 4 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
2/27/2020 - 5 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
2/27/2020 - 5 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP